Otsuka Pharmaceutical Co., Ltd.

Release Summary

Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S announced that the U.S. Food and Drug Administration approved the labeling update of Abilify Maintena® for extended-release injectable suspension.